Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_assertion type Assertion NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_head.
- NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_assertion description "[Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_provenance.
- NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_assertion evidence source_evidence_literature NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_provenance.
- NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_assertion SIO_000772 20126311 NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_provenance.
- NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_assertion wasDerivedFrom befree-20150227 NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_provenance.
- NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_assertion wasGeneratedBy ECO_0000203 NP622825.RAkpNAF6Z7l6JRyqjGvEjiX_-PdW92065E2XAJ5J7QFjM130_provenance.